Eosinophilic pediatric ABPM lacking fungal sensitization responsive to anti–IL-5
A pediatric patient with allergic bronchopulmonary mycosis with high-attenuation mucus and no fungal sensitization achieved remission with anti-IL-5 therapy, highlighting the diagnostic value of high-attenuation mucus and the role of eosinophilic inflammation in non-IgE-dominant airway disease.
Authors
- Takayasu Nomura (ORCID: https://orcid.org/0000-0002-1915-2480)
- Yoshihiro Kanemitsu (ORCID: https://orcid.org/0000-0002-1529-9477)
- Shinji Saitoh (ORCID: https://orcid.org/0000-0001-6911-3351)
- Akiko Nakaoka
- Keinosuke Hizuka (ORCID: https://orcid.org/0000-0002-5650-7834)
- Shigeharu Ueki (ORCID: https://orcid.org/0000-0002-3537-7735)
- Hisashi Tanida
- Mari Mizutani (ORCID: https://orcid.org/0000-0001-5718-6764)
Institutions
- Akita University (JP)
- Nagoya City University (JP)
Publication Details
- Journal
- Journal of Allergy and Clinical Immunology Global
- Published
- 2025-11-20
- DOI
- https://doi.org/10.1016/j.jacig.2025.100612
- Primary Topic
- Antifungal resistance and susceptibility
- Type
- article
- Field-Weighted Citation Impact
- 0.00